NAYA: Prakiraan konsensus analis NAYA Biosciences Corp

This daily price chart for NAYA Biosciences (NAYA) reflects asset dynamics with a value of 6.01. NAYA Biosciences (NAYA) is recruiting leading biotechnologists and physicians to develop targeted therapies. The production cycle relies on external certified contractors in the US, which stabilizes supplies. Meanwhile, management is currently establishing an internal hierarchy, and the company's investment attractiveness depends on the outcomes of primary tests.

NAYA Prakiraan konsensus analis NAYA Biosciences (04.07.2022 - 28.04.2025)

Rincian analitis perusahaan NAYA Bio (NAYA)

Indikator analitis utama NAYA Biosciences Corp (NAYA):

Kurs saham nayabiosciences.com|NAYA - Prakiraan konsensus analis|Kapitalisasi pasar NAYA Bio

Analisis fundamental perusahaan:nayabiosciences.com (NAYA)

Produk asli NAYA Bio

This indicator represents the weighted average target price of the asset over a one-year horizon, aggregating professional analyst forecasts to assess fundamental growth potential. The current market consensus for NAYA Biosciences (NAYA) is 6.01, reflecting market expectations regarding the capitalization of NAYA Biosciences as it develops innovative antibodies and achieves clinical success in oncology therapies.

Perusahaan pesaing

beigene.com - Prakiraan gabungan firma investasi|Prakiraan konsensus analis HALO (Halozyme)|Prakiraan konsensus analis Revolution Medicines Inc RVMD|AAPG: Target konsensus|Rata-rata rega prakiraan CG Oncology Therapeutics|URGN: Prakiraan konsensus analis|bicara.com (BCAX) - Prakiraan konsensus analis|PSNL (Personalis) - Prakiraan konsensus analis|Target konsensus Erasca Inc (ERAS)|Prakiraan konsensus analis DCTH|Prakiraan konsensus analis Y-mAbs Corp (YMAB)|Bagan rega target Aura Biosciences, Inc. AURA|CADL: Prakiraan gabungan firma investasi|Accuray - Prakiraan konsensus analis|SELLAS Life Sciences (SLS) - Target konsensus|ACTU: Prakiraan konsensus analis|Rata-rata rega prakiraan Citius Oncology Inc (CTOR)|Bagan rega target TuHURA Biosciences Inc.|TARA: Konsensus nilai wajar|Target konsensus FATE (Fate Therapeutics)|WHWK (aadibio.com) - Konsensus nilai wajar|Prakiraan konsensus analis TCRX (TScan Therapeutics, Inc.)|CSBR - Target konsensus|XBIT: Target konsensus|CVM - Prakiraan konsensus analis|OS Therapies (OSTX) - Bagan rega target|Radiopharm Theranostics Ltd - Konsensus nilai wajar|ARTV (Artiva Biotherapeutics Inc.) - Prakiraan konsensus analis|Rata-rata rega prakiraan Adlai Nortye Limited ANL|Bagan rega target Veru Inc. (VERU)|tempesttx.com - Prakiraan gabungan firma investasi|Prakiraan konsensus analis XLO (Xilio Therapeutics)|Prakiraan konsensus analis Renovaro Biosciences RENB|MURA: Target konsensus|Rata-rata rega prakiraan Kairos Pharma Ltd|OKUR: Prakiraan konsensus analis|CytoMed Therapeutics Limited (GDTC) - Prakiraan konsensus analis|Target konsensus CRIS|APLM: Konsensus nilai wajar|Prakiraan konsensus analis THAR|Bagan rega target ADVB (advanbiomed.com)|Prakiraan konsensus analis GNPX (Genprex, Inc.)|Target median analis Calidi Biotherapeutics Inc. (CLDI)|SBFM - Bagan rega target|Rata-rata rega prakiraan Xenetic Biosciences|Salarius (SLRX) - Bagan rega target|PPBT - Target median analis|AONC (American Oncology Network Inc) - Prakiraan konsensus analis|Target konsensus beigene.com (BGNE)|Prakiraan konsensus analis CKPT|Target median analis Elevation Oncology Inc.|Prakiraan konsensus analis ICAD (iCAD)|Ikena Oncology Inc. (IKNA) - Rata-rata rega prakiraan|NTBL - Bagan rega target|VIRX (Viracta Therapeutics) - Prakiraan gabungan firma investasi|MOR: Prakiraan konsensus analis|Target konsensus Ascentage Pharma Group International